Literature DB >> 16792543

Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection.

J F Gallegos-Orozco1, J I Arenas, H E Vargas, K V Kibler, J K Wilkinson, M Nowicki, M Radkowski, J Nasseri, J Rakela, T Laskus.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) translation is initiated in a cap-independent manner by an internal ribosome entry site (IRES) located within the 5' untranslated region (5'UTR). Sequence changes in this region could affect translation efficiency and presumably viral replication. AIM: To determine translation efficiency of 5'UTR variants developing during post-transfusion hepatitis C in two immunocompetent subjects and in two immunosuppressed liver recipients with recurrent HCV.
METHODS: Sequential samples were screened for 5'UTR changes by single-strand conformation polymorphism followed by cloning and sequencing whenever band pattern suggested sequence changes. 5'UTR variants were tested for IRES activity using a bicistronic dual luciferase expression plasmid transfected into HepG2 and Huh7 cell-lines.
RESULTS: In the transfused patients, translation efficiency of 5'UTR variants from early post-transfusion samples was 5.1- to 13.7-fold higher than that of predominant variants found in late follow-up samples. Post-transplant variants in the other two patients had 2.6- to 5.9-fold higher translation efficiency than those present only in pretransplant samples.
CONCLUSION: In the immunocompetent host there may be selection of low translation efficiency HCV variants over the course of infection. However, in immunosuppressed subjects the opposite seems to be true as low translation efficiency variants are superseded by high translation efficiency variants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16792543     DOI: 10.1111/j.1365-2893.2006.00724.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  5 in total

Review 1.  The quasispecies nature and biological implications of the hepatitis C virus.

Authors:  Sarah L Fishman; Andrea D Branch
Journal:  Infect Genet Evol       Date:  2009-08-08       Impact factor: 3.342

Review 2.  Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site.

Authors:  Sergey M Dibrov; Jerod Parsons; Maia Carnevali; Shu Zhou; Kevin D Rynearson; Kejia Ding; Emily Garcia Sega; Nicholas D Brunn; Mark A Boerneke; Maria P Castaldi; Thomas Hermann
Journal:  J Med Chem       Date:  2013-11-05       Impact factor: 7.446

3.  Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin.

Authors:  Iwona Bukowska-Ośko; Agnieszka Pawełczyk; Karol Perlejewski; Natalia Kubisa; Kamila Caraballo Cortés; Magdalena Rosińska; Rafał Płoski; Maria Fic; Justyna Kaźmierczak; Marta Popiel; Piotr Ząbek; Andrzej Horban; Marek Radkowski; Tomasz Laskus
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

4.  Analysis of genotype 1b hepatitis C virus IRES in serum and peripheral blood mononuclear cells in patients treated with interferon and ribavirin.

Authors:  Iwona Bukowska-Ośko; Kamila Caraballo Cortés; Agnieszka Pawełczyk; Rafał Płoski; Maria Fic; Karol Perlejewski; Urszula Demkow; Hanna Berak; Andrzej Horban; Tomasz Laskus; Marek Radkowski
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

5.  Quasispecies Changes with Distinctive Point Mutations in the Hepatitis C Virus Internal Ribosome Entry Site (IRES) Derived from PBMCs and Plasma.

Authors:  Luca Mercuri; Emma C Thomson; Joseph Hughes; Peter Karayiannis
Journal:  Adv Virol       Date:  2018-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.